Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Calignano

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1995
Synthesis and in vitro activities of highly potent and selective tripeptide antagonists of the neurokinin NK-1 receptorG Caliendo, G Greco, P Grieco, et al.
Mediators of Inflammation|March 28, 2013
Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanismL Di Cesare Mannelli, G D'Agostino, A Pacini, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1996
Modification of the potent peptide FK888 with unusual aminoacids: effects on activity on neurokinin receptorsG Caliendo, G Greco, P Grieco, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 21, 1998
Synthesis and in vitro activities of NK-1 antagonists derived from L-tryptophanG Caliendo, F Fiorino, P Grieco, et al.
Peptides|January 1, 1992
Substance P inactivation by transglutaminase in vitroP Persico, A Calignano, F Mancuso, et al.
Life Sciences|June 17, 1998
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinomaA W Bak, W McKnight, P Li, et al.
Nature|November 18, 2000
Bidirectional control of airway responsiveness by endogenous cannabinoidsA Calignano, I Kátona, F Désarnaud, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 11, 1999
Synthesis and structure-activity relationships of 2-(substituted phenyl)-3-[3-(N,N-dimethylamino)propyl]-1,3-thiazolidin-4-ones acting as H1-histamine antagonistsM V Diurno, O Mazzoni, G Correale, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 20, 2016
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosisNs Orefice, A Carotenuto, G Mangone, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 2000
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritisA Ianaro, C Cicala, A Calignano, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Farmaco (Societa Chimica Italiana : 1989)|November 1, 1995
Synthesis and in vitro activities of highly potent and selective tripeptide antagonists of the neurokinin NK-1 receptorG Caliendo, G Greco, P Grieco, et al.
Mediators of Inflammation|March 28, 2013
Palmitoylethanolamide is a disease-modifying agent in peripheral neuropathy: pain relief and neuroprotection share a PPAR-alpha-mediated mechanismL Di Cesare Mannelli, G D'Agostino, A Pacini, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1996
Modification of the potent peptide FK888 with unusual aminoacids: effects on activity on neurokinin receptorsG Caliendo, G Greco, P Grieco, et al.
Farmaco (Societa Chimica Italiana : 1989)|March 21, 1998
Synthesis and in vitro activities of NK-1 antagonists derived from L-tryptophanG Caliendo, F Fiorino, P Grieco, et al.
Peptides|January 1, 1992
Substance P inactivation by transglutaminase in vitroP Persico, A Calignano, F Mancuso, et al.
Life Sciences|June 17, 1998
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinomaA W Bak, W McKnight, P Li, et al.
Nature|November 18, 2000
Bidirectional control of airway responsiveness by endogenous cannabinoidsA Calignano, I Kátona, F Désarnaud, et al.
Farmaco (Societa Chimica Italiana : 1989)|November 11, 1999
Synthesis and structure-activity relationships of 2-(substituted phenyl)-3-[3-(N,N-dimethylamino)propyl]-1,3-thiazolidin-4-ones acting as H1-histamine antagonistsM V Diurno, O Mazzoni, G Correale, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 20, 2016
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosisNs Orefice, A Carotenuto, G Mangone, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 2000
Anti-very late antigen-1 monoclonal antibody modulates the development of secondary lesion and T-cell response in experimental arthritisA Ianaro, C Cicala, A Calignano, et al.
Pageof 7